Table 4.
Multivariable Cox modelsa
OS |
PFS |
NRM |
Relapse |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HR | 95% CI | p-value | HR | 95% CI | p-value | HR | 95% CI | p-value | HR | 95% CI | p-value | |||||
| ||||||||||||||||
Ageb | 1.27 | 1.08 | 1.49 | 0.005 | 1.11 | 0.95 | 1.30 | 0.19 | 1.34 | 1.02 | 1.76 | 0.036 | 0.99 | 0.82 | 1.20 | 0.93 |
Patient-Donor Sex | ||||||||||||||||
M<-F vs. Other | 1.08 | 0.90 | 1.30 | 0.39 | 1.03 | 0.86 | 1.23 | 0.76 | 1.10 | 0.82 | 1.49 | 0.53 | 1.00 | 0.81 | 1.25 | 0.98 |
HLA type | ||||||||||||||||
MUD vs MRD | 1.06 | 0.90 | 1.27 | 0.48 | 0.98 | 0.83 | 1.15 | 0.78 | 1.65 | 1.22 | 2.22 | 0.001 | 0.77 | 0.63 | 0.93 | 0.008 |
Mismatched vs MRD | 1.26 | 0.94 | 1.68 | 0.12 | 1.08 | 0.82 | 1.43 | 0.59 | 1.95 | 1.25 | 3.03 | 0.003 | 0.80 | 0.55 | 1.15 | 0.23 |
Patient or Donor CMV | ||||||||||||||||
seropositivity: Y vs. N | 1.06 | 0.90 | 1.25 | 0.47 | 1.02 | 0.87 | 1.19 | 0.83 | 1.14 | 0.87 | 1.51 | 0.34 | 0.97 | 0.80 | 1.17 | 0.73 |
Disease Relapse Index | ||||||||||||||||
Intermediate vs. Low | 1.73 | 1.32 | 2.26 | <.0001 | 1.93 | 1.50 | 2.49 | <.0001 | 1.12 | 0.76 | 1.66 | 0.56 | 2.50 | 1.78 | 3.52 | <.0001 |
High/Very high vs. Low | 2.68 | 2.02 | 3.56 | <.0001 | 2.98 | 2.28 | 3.89 | <.0001 | 1.22 | 0.79 | 1.88 | 0.37 | 4.61 | 3.24 | 6.56 | <.0001 |
Year of Transplantation | 0.97 | 0.93 | 1.02 | 0.28 | 0.95 | 0.91 | 1.00 | 0.03 | 0.98 | 0.91 | 1.07 | 0.69 | 0.94 | 0.89 | 1.00 | 0.04 |
CD34 cells/kg (×106)c | ||||||||||||||||
<=4 vs <4-15 | 1.28 | 0.99 | 1.66 | 0.06 | 1.31 | 1.03 | 1.66 | 0.03 | 1.37 | 0.90 | 2.09 | 0.15 | 1.21 | 0.91 | 1.63 | 0.19 |
>15 vs <4-15 | 1.20 | 0.94 | 1.53 | 0.15 | 1.17 | 0.93 | 1.49 | 0.19 | 0.83 | 0.53 | 1.32 | 0.43 | 1.33 | 1.01 | 1.76 | 0.045 |
ECOG performance Status | ||||||||||||||||
1 vs. 0 | 1.31 | 1.07 | 1.58 | 0.007 | 1.29 | 1.07 | 1.54 | 0.007 | 1.21 | 0.89 | 1.66 | 0.23 | 1.32 | 1.05 | 1.65 | 0.017 |
2-3 vs. 0 | 1.58 | 1.18 | 2.11 | 0.002 | 1.42 | 1.08 | 1.88 | 0.01 | 1.89 | 1.19 | 3.00 | 0.007 | 1.26 | 0.89 | 1.79 | 0.20 |
missing vs. 0 | 1.29 | 0.99 | 1.67 | 0.06 | 1.23 | 0.96 | 1.58 | 0.10 | 1.08 | 0.69 | 1.67 | 0.75 | 1.31 | 0.96 | 1.78 | 0.09 |
Graft Source | ||||||||||||||||
BM vs. PBSC | 0.77 | 0.51 | 1.15 | 0.19 | 0.81 | 0.56 | 1.19 | 0.29 | 0.58 | 0.31 | 1.07 | 0.08 | 1.02 | 0.63 | 1.66 | 0.94 |
Grade 2-4 aGVHD | 1.50 | 1.26 | 1.78 | <.0001 | 1.19 | 1.00 | 1.42 | 0.05 | 2.28 | 1.75 | 2.98 | <.0001 | 0.74 | 0.57 | 0.96 | 0.02 |
Gr. ≥3 Infection within D100 | 1.89 | 1.57 | 2.27 | <.0001 | 1.71 | 1.40 | 2.08 | <.0001 | 3.39 | 2.45 | 4.70 | <.0001 | 1.14 | 0.88 | 1.48 | 0.33 |
WBC risk group | ||||||||||||||||
1 vs. 0 | 1.64 | 1.26 | 2.13 | 0.0002 | 1.49 | 1.16 | 1.92 | 0.0017 | 2.04 | 1.34 | 3.11 | 0.0009 | 1.27 | 0.93 | 1.74 | 0.13 |
2 vs. 0 | 3.06 | 2.36 | 3.97 | <.0001 | 2.88 | 2.23 | 3.73 | <.0001 | 3.23 | 2.15 | 4.85 | <.0001 | 2.86 | 2.03 | 4.03 | <.0001 |
stratified by conditioning intensity.
dichotomized as 1 if age>=40 in MAC or >=60 in RIC; 0 otherwise.
5 missing CD34 are combined with CD34<=4 because of a similar hazard ratio.
d: time dependent variable. MUD: matched unrelated donor; MRD: matched related donor.